通过ASCL1进行直接重编程:将腹腔中脑星细胞转化为多巴胺能神经元,用于帕金森病治疗
Sang Hui Yong1, Sang-Mi Kim2, Gyeong Woon Kong1
1Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Korea.
BMB reports
|April 22, 2024
概括
研究人员开发了一种新的帕金森病 (PD) 疗法,通过使用ASCL1.1直接将星球细胞重新编程为多巴胺基神经元 (iDAN). 这种新的方法为PD提供了潜在的初级治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 干细胞生物学 干细胞生物学
- 分子生物学分子生物学
背景情况:
- 帕金森病 (PD) 涉及黑体中多巴胺能神经元的渐进性退化.
- 目前的PD治疗方法,包括药物和手术,缺乏初级治愈疗法.
- 直接重编程为PD的细胞替代疗法提供了一个潜在的策略.
研究的目的:
- 为帕金森病 (PD) 开发一种新的治疗方法,通过诱导天体细胞直接重编程成为多巴胺基神经元 (iDAN).
- 调查阿切特-斯库特家族bHLH转录因子1 (ASCL1) 在天体细胞直接转化为iDANs中的作用.
主要方法:
- 在使用逆转录病毒的腹腔中脑 (VM) 天体细胞中过度表达GFP标记的ASCL1.
- 在iDAN转换介质中培养重新编程的星球细胞一周.
- 使用TH (铁氨酸氧酶) 和TUJ1 (β-III素) 等标记物的细胞分化分析.
主要成果:
- 星球细胞在培养后一周内成功地被重新编程成iDAN.
- 7天后出现表达多巴胺基标记物的分化细胞 (TH+/TUJ1+),2周后增加了成熟神经元的数量.
- 只有VM天体细胞,而不是皮质天体细胞,仅仅通过ASCL1证明了成功的重编程.
结论:
- 腹腔中脑天体细胞可以直接通过ASCL1作为单个转录因子被重新编程成多巴胺基神经元 (iDAN).
- 这一发现表明,通过产生患者特异性的多巴胺基神经元来治疗帕金森病的潜在基于细胞的治疗方法.
- 这项研究突出了ASCL1在驱动神经发生的潜力,并为PD治疗开发提供了新的途径.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


